Abstract
We report the synthesis of 2',3'-didehydro-2',3'-dideoxyuridine (d4U) and 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives and their evaluation against HIV-1 and HIV-2. In addition, we conducted molecular modeling studies on both d4U and ddU monophosphates to investigate their second phosphorylation process. The findings from the modeling studies provide compelling evidence for the lack of anti-HIV activity of d4U phosphoramidates, in contrast with the corresponding ddU phosphoramidates.
| Original language | English |
|---|---|
| Pages (from-to) | 3666-9 |
| Number of pages | 4 |
| Journal | Bioorganic & Medicinal Chemistry Letters |
| Volume | 17 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 1 Jul 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Amides
- Anti-HIV Agents
- Chemistry, Pharmaceutical
- Dideoxynucleosides
- Drug Design
- HIV-1
- HIV-2
- Models, Chemical
- Models, Molecular
- Nucleoside-Phosphate Kinase
- Nucleosides
- Phosphates
- Phosphoric Acids
- Phosphorylation
- Thymidine Monophosphate
Fingerprint
Dive into the research topics of 'Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver